CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy

Pharmacogenomics,Volume 21, Issue 1, Page 7-21, January 2020.

Source: Future Medicine: Pharmacogenomics - December 17, 2019 Category: Genetics & Stem Cells Authors: Fabiana Dalla Vecchia Genvigir Antony Brayan Campos-Salazar Claudia Rosso Felipe Helio Tedesco-Silva Jos é Osmar Medina-Pestana Sonia de Quateli Doi Alvaro Cerda Mario Hiroyuki Hirata Mar ía José Herrero Salvador Francisco Ali ño Rosario Dominguez Cre Source Type: research